Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II study of pre-operative versus peri-operative DOX in resectable locally advanced gastric cancer
2010-020189-37Phase 2Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of docetaxel, oxaliplatin and capecitabine in gastric adenocarcinoma and gastric cancer (GC) (2 arms), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Primary endpoint: Percentage of patients receiving all planned chemotherapy cycles. Started Mar 2012; status: completed.
02
Drugs
docetaxeloxaliplatincapecitabine
03
Conditions
gastric adenocarcinomagastric cancer (GC)
Beyond the preview
Go deeper on 2010-020189-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020189-37.